Alexandra MacLean - 29 Jun 2023 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Role
Chief Executive Officer, Director
Signature
/s/ David Jin, attorney-in-fact
Issuer symbol
ATXI
Transactions as of
29 Jun 2023
Net transactions value
$0
Form type
4
Filing time
03 Jul 2023, 13:05:30 UTC
Previous filing
03 Aug 2022
Next filing
25 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXI Employee stock option (right to buy) Award $0 +800,000 $0.000000 800,000 29 Jun 2023 Common Stock 800,000 $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in accordance with the following schedule: (i) 25% of the shares subject to the option vest on August 1, 2023; (ii) 25% of the shares subject to the option vest on August 1, 2024; (iii) 25% of the shares subject to the option vest on August 1, 2025; and (iv) 25% of the shares subject to the option vest on August 1, 2026.